Showing results (21-30 of 40) with videos related to

Sort By:
Pageof 4
Biochimica Et Biophysica Acta. Reviews on Cancer|August 13, 2017
Clinical value of ctDNA in upper-GI cancers: A systematic review and meta-analysisA Creemers, S Krausz, M Strijker, et al.
BMC Cancer|December 29, 2022
Stereotactic ablative radiotherapy or best supportive care in patients with localized pancreatic cancer not receiving chemotherapy and surgery (PANCOSAR): a nationwide multicenter randomized controlled trial according to a TwiCs designD Doppenberg, M G Besselink, C H J van Eijck, et al.
Acta Oncologica (Stockholm, Sweden)|December 22, 2017
Translating the ABC-02 trial into daily practice: outcome of palliative treatment in patients with unresectable biliary tract cancer treated with gemcitabine and cisplatinJ Dierks, M P Gaspersz, A Belkouz, et al.
Trials|October 29, 2022
A nationwide randomized controlled trial on additional treatment for isolated local pancreatic cancer recurrence using stereotactic body radiation therapy (ARCADE)I W J M van Goor, L A Daamen, M G Besselink, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|December 17, 2024
Perspectives of the medical oncologist regarding adjuvant chemotherapy for pancreatic cancer: An international expert survey and case vignette studyN C Biesma, M U J E Graus, G A Cirkel, et al.
Annals of Surgery|September 30, 2025
Impact of Merging two high-volume Centers on Patient Outcome: 1000 Consecutive PancreatoduodenectomiesIngmar F Rompen, Julia E Menso, Ewout Ingwersen, et al.
ESMO Gastrointestinal Oncology|March 11, 2026
Preference versus protocol: oncology clinicians' perspectives on central venous access for administration of chemotherapy in pancreatic cancerM U J E Graus, R A L Willems, N C Biesma, et al.
The British Journal of Surgery|April 8, 2020
Gemcitabine-based adjuvant chemotherapy in subtypes of ampullary adenocarcinoma: international propensity score-matched cohort studyA L Moekotte, G Malleo, S van Roessel, et al.
BMC Cancer|March 24, 2021
Total neoadjuvant FOLFIRINOX versus neoadjuvant gemcitabine-based chemoradiotherapy and adjuvant gemcitabine for resectable and borderline resectable pancreatic cancer (PREOPANC-2 trial): study protocol for a nationwide multicenter randomized controlled trialQ P Janssen, J L van Dam, B A Bonsing, et al.
Annals of Surgery|August 2, 2021
Survival Benefit Associated With Resection of Locally Advanced Pancreatic Cancer After Upfront FOLFIRINOX Versus FOLFIRINOX Only: Multicenter Propensity Score-matched AnalysisLilly J H Brada, Lois A Daamen, Lisa G Magermans, et al.
Pageof 4